摘要
平衡抗栓获益及其出血风险是临床抗栓治疗中的重点与难点。本文分析临床药师参与的1例高血栓风险的心衰患者经皮冠状动脉介入(PCI)术后抗栓及止血治疗,探讨严重肾功能不全患者的抗栓治疗以及发生出血后的止血治疗策略。为同类疾病患者的个体化抗栓治疗及止血治疗提供参考。
Balancing the benefits and bleeding risk of antithrombotic therapy is the key and difficult point in clinical antithrombotic therapy.This paper analyzed the antithrombotic and hemostatic treatment after percutaneous coronary intervention in a heart failure patient with high risk of thrombosis,and discussed the antithrombotic treatment in a patient with severe renal insufficiency and the hemostatic treatment strategy after bleeding.This article can provide reference for individualized antithrombotic therapy and hemostatic therapy for patients with similar diseases.
作者
祁蕙
张伟霞
Qi Hui;Zhang Weixia(Department of Pharmacy,Chengdu Sixth People’s Hospital,Chengdu 610051,China;Department of Pharmacy,Ruijin Hospital,Shanghai Jiaotong University School of Medicine)
出处
《药物流行病学杂志》
CAS
2020年第2期133-135,140,共4页
Chinese Journal of Pharmacoepidemiology
关键词
经皮冠状动脉介入术
心衰
冠心病
肾功能不全
抗栓
止血
药学监护
Percutaneous coronary intervention
Heart failure
Coronary heart disease
Renal insufficiency
Antithrombotic
Hemostasis
Pharmaceutical care